A similar situation may occur for the Ca2+ channel blockers verapamil and diltiazem: these drugs elicit an anticancer effect by inhibiting P glycoprotein and multidrug resistance, but have also been shown to inhibit VGSCs in metastatic breast cancer cells (Roger et al., 2004). Here, ABCB1 is linked to breast cancer.